Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/James Picariello
EB
James Picariello
Exane BNP Paribas
Wall Street Analyst
★★★☆☆
#1423
on 13Foresight · ranked by our own returns
50%
Success Rate
+13.0%
Average Return
8 of 16 calls profitable · -4.1% vs benchmark
📈 Across the calls we could measure, roughly 50% of James Picariello's ratings turned a profit when each position was held for 1 year — averaging +13.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

1 Buy 2 Hold 1 Sell
James's Stock Coverage 20 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
F
Ford Motor
 May 04, 2026 HOLD Buy
-0.2% avg upside
40 analysts
$13.00
7.53% Downside
 +22.9%
VGNT
Versigent Limited
 Apr 28, 2026 BUY Strong Buy
-1.2% avg upside
9 analysts
$41.00
10.56% Downside
 ·
TSLA
Tesla
 Oct 16, 2025 SELL Buy
-12.5% avg upside
82 analysts
$307.00
23.25% Downside
 +6.6%
GT
GoodYear Tire
 Aug 08, 2025 HOLD Buy
+48.4% avg upside
15 analysts
$9.00
45.36% Upside
 -28.2%
DAN
Dana Incorporated
 Jun 12, 2025 BUY Strong Buy
+9.9% avg upside
16 analysts
$19.00
34.91% Downside
 +80.4%
RIVN
Rivian Automotive
 May 19, 2025 BUY Hold
+2.7% avg upside
36 analysts
$20.00
21.08% Upside
 -20.8%
MBLY
Mobileye Global, Inc. Class A
 Apr 23, 2025 HOLD Strong Buy
+105.4% avg upside
33 analysts
$11.00
30.10% Upside
 -34.1%
BWA
BorgWarner
 Mar 18, 2025 BUY Strong Buy
-16.4% avg upside
28 analysts
$36.00
49.90% Downside
 +83.2%
GNTX
Gentex
 Jul 30, 2024 HOLD Buy
+9.2% avg upside
13 analysts
$34.00
31.03% Upside
 -10.8%
ADNT
Adient
 Jul 01, 2024 HOLD Hold
+26.1% avg upside
18 analysts
$26.00
25.26% Upside
 -14.7%
TSE:MG
Magna International
 Jul 01, 2024 BUY Buy
-6.1% avg upside
30 analysts
 — ·
VC
Visteon
 Dec 13, 2023 HOLD Strong Buy
+9.6% avg upside
22 analysts
$130.00
14.31% Upside
 -23.6%
LCID
Lucid Group
 Aug 11, 2023 SELL Sell
+183.8% avg upside
19 analysts
$5.00
6.74% Downside
 +52.0%
LCDX
Caliber Imaging & Diagnostic
 Aug 11, 2023 SELL Sell
+726090.4% avg upside
10 analysts
$5.00
833233.31% Upside
 ·
LEA
Lear
 Jun 01, 2023 BUY Buy
+0.1% avg upside
24 analysts
 — +1.9%
APTV
Aptiv
 Apr 11, 2022 BUY Strong Buy
+39.6% avg upside
34 analysts
$160.00
151.22% Upside
 -3.0%
DCH
Dauch Corporation
 Apr 11, 2022 HOLD Buy
+47.9% avg upside
19 analysts
$7.00
11.03% Upside
 ·
ALV
Autoliv
 Mar 24, 2020 HOLD Buy
+0.5% avg upside
37 analysts
 — +92.2%
FLS
Flowserve
 Nov 01, 2017 HOLD Buy
-7.8% avg upside
22 analysts
 — +7.8%
MIDD
The Middleby
 Oct 16, 2017 HOLD Strong Buy
-1.1% avg upside
15 analysts
 — -4.2%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
James Picariello — Frequently Asked Questions
How accurate are James Picariello's stock ratings?
Based on the calls 13Foresight could measure, about 50% of James's ratings were profitable over a one-year hold, with an average return of +13.0% per rating, or -7.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is James ranked on 13Foresight?
James Picariello is currently ranked #1423 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does James cover?
James most recently has ratings on F, VGNT, TSLA, GT, DAN, RIVN, MBLY, BWA, GNTX, ADNT, TSE:MG, VC and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.